PASITHEA THERAPEUTICS CORP. Cash Equivalents, at Carrying Value
PASITHEA THERAPEUTICS CORP. (KTTA) had Cash Equivalents, at Carrying Value of $45.70 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash Equivalents, at Carrying Value $45.70M.
- 2026-03-31: Cash Equivalents, at Carrying Value $50.40M.
- 2025-12-31: Cash Equivalents, at Carrying Value $55.20M; Cash Equivalents, at Carrying Value as first filed $53.40M.
- 2025-09-30: Cash Equivalents, at Carrying Value $3.00M.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $45.70M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $50.40M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $55.20M 10-Q · filed 2026-08-14 | $53.40M 10-K · filed 2026-03-30 |
| 2025-09-30 | $3.00M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.20M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $4.10M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $6.10M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $4.50M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $7.10M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $10.60M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $13.40M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $10.30M 10-Q · filed 2023-11-13 | |
| 2023-03-31 | $16.63K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |